***Background.*** CRE cause serious infections which are difficult to treat and prolonged intestinal carriage is common. A 14 year old girl had a recent diagnosis of hemophagocytic lymphohistiocytosis treated with corticosteroids and etopiside. She had previously received prolonged broad spectrum antibiotics for infection with *Pseudomonas aeruginosa*. She developed a new fever, and blood cultures grew a highly resistant *Klebsiella pneumoniae* (KPC) which was carbapenemase-positive by the modified Hodge test. Despite administration of antibiotics with *in vitro*activity, her blood cultures remained persistently positive for 5 weeks. During that time she developed septic arthritis of one shoulder and both hips. The bloodstream infection was finally cleared by a combination of extended-infusion doripenem, colistin, rifampin, and plazomicin. 10 months after the first acute infection, she developed a KPC osteomyelitis of the right femur and was treated with the same antibiotics. Stool cultures continued to show a predominance of the KPC.

***Methods.*** Family members were screened as potential donors for a fecal microbiota transplant (FMT). We excluded anyone who had recently received antibiotics and tested donor stools for *C. difficile*, ova and parasites, rotavirus and any bacteria that showed high level resistance. A younger brother in excellent health was selected. The patient underwent a 48 hour bowel cleanse with polyethylene glycol prior to the procedure. A nasoduodenal tube (NDT) was placed and omeprazole was administered. The FMT specimen was prepared immediately prior to the procedure by homogenizing 30 grams of fresh donor stool with 70 ml of normal saline and filtering the suspension twice through coffee filters. 25 ml of the filtrate was then infused into the NDT and flushed with 30 ml of normal saline. Post procedure she received VSL\#3, a probiotic, for 6 months.

***Results.*** 3 stool cultures taken during 8 months following the FMT showed no KPC. The patient has had no recurrence of clinical infection in the 1.5 years following FMT.

***Conclusion.*** This is the first reported use of FMT to eradicate colonization with KPC. For patients with recurrent clinical infections due to highly resistant enteric organisms, this therapy should be considered for source control.
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